|
TP1474 |
LXW7
|
|
Integrin
|
|
LXW7 is an octamer disulfide cyclic peptide and αvβ3 integrin ligand, acts as a potent and specific endothelial progenitor cells (EPCs) and endothelial cells (ECs) targeting ligand. LXW7 is a disulfide cyclic octa-pepti... |
|
T6812L |
Cyclo(-RGDfK) TFA
|
|
Integrin
|
|
Cyclo(-RGDfK) is a selective αvβ3 integrin inhibitor(IC50 : 0.94 nM). |
|
T6812 |
Cyclo(-RGDfK)
|
Cyclo (-RGDfK) |
Integrin
|
|
Cyclo(-RGDfK) (Cyclo (-RGDfK)) is an effective and specific αvβ3 integrin inhibitor. |
|
TP1879L1 |
P11 acetate
|
|
Integrin
|
|
P11 acetate is an integrin αvβ3-vitronectin interaction antagonist(IC50 = 2.74 nM). |
|
T6813 |
Cyclo(RGDyK) trifluoroacetate
|
Cyclo(RGDyK) |
Integrin
|
|
Cyclo(RGDyK) trifluoroacetate is a potent and selective αVβ3 integrin inhibitor with IC50 of 20 nM. |
|
T6657 |
SB273005
|
|
Integrin
|
|
SB273005 is a potent integrin inhibitor with Ki of 1.2 nM and 0.3 nM for αvβ3 receptor and αvβ5 receptor, respectively. |
|
T2494 |
Cilengitide
|
EMD 121974 |
Integrin
,
Autophagy
|
|
Cilengitide (EMD 121974) is a potent integrin inhibitor for the αvβ3/5 receptor (IC50: 4.1/79 nM, in cell-free assays); ~10-fold selectivity against gpIIbIIIa. |
|
TQ0250 |
CWHM-12
|
|
Integrin
|
|
CWHM-12 is a potent inhibitor of αV integrins (IC50s of 0.2/0.8/1.5/1.8 nM for αvβ8/αvβ3/αvβ6/αvβ1). |
|
TP2148 |
LXW7 TFA (1313004-77-1 free base)
|
LXW7 TFA |
Integrin
|
|
LXW7 TFA, a cyclic peptide containing Arg-Gly-Asp (RGD), is an integrin αvβ3 inhibitor with an anti-inflammatory effect. LXW7 has a high binding affinity to αvβ3 integrin (IC50: 0.68 μM). It increases the phosphorylation... |
|
T16085 |
MK-0429
|
L-000845704 |
Others
|
|
MK-0429 is an orally active, selective, and nonpeptide antagonist of αvβ3 integrin (IC50: 80 nM). |
|
T6806 |
Cilengitide TFA
|
|
Integrin
,
Autophagy
|
|
Cilengitide is a potent integrin inhibitor for αvβ3 receptor and αvβ5 receptor with IC50 of 4.1 nM and 79 nM in cell-free assays, respectively; ~10-fold selectivity against gpIIbIIIa. Phase 2. |
|
T16851 |
SB-267268
|
|
Others
|
|
SB-267268 inhibits human and mouse αvβ3 (IC50s: 0.68 and 0.29 nM, respectively). SB-267268 is a selective and nonpeptidic alpha(v)beta3 and alpha(v)beta5 integrins antagonist (Kis: 0.9, 0.5 and 0.7 nM for human αvβ3, mon... |
|
TP2390 |
Maraciclatide
|
NC-100692,NC 100692,NC100692 |
|
|
Maraciclatide is a radiopharmaceutical targeting αvβ3 integrin. |
|
T11663 |
Integrin-IN-2
|
|
Others
|
|
|
|
T8726 |
Cyclo(RGDyK)
|
|
Integrin
|
|
Cyclo(RGDyK) is a potent and selective αVβ3 integrin inhibitor with IC50 of 20 nM. |
|
TP1459L |
Gly-Arg-Gly-Asp-Ser acetate(96426-21-0 free base)
|
|
Integrin
|
|
Gly-Arg-Gly-Asp-Ser (GRGDS) acetate is a cell binding protein domain derived from the cell-binding region of fibronectin. |
|
T69460 |
TSRI265
|
|
|
|
TSRI265 is a novel αvβ3 ligand, disrupting the integrin-MMP2 interaction and showing antiangiogenic activit, inhibiting angiogenesis and tumor growth in vivo. |
|
T75724 |
LXW7 TFA
|
|
|
|
LXW7 TFA, a cyclic peptide encompassing Arg-Gly-Asp (RGD), serves as an inhibitor of integrin αvβ3. It demonstrates high binding affinity towards αvβ3 integrin, evidenced by an IC50 value of 0.68 μM. Additionally, LXW7 T... |
|
T15584 |
Integrin Antagonists 27
|
|
Others
|
|
Integrin Antagonists 27 is a small molecule integrin αvβ3 antagonist. It has a binding affinity of 18 nM and as a novel anticancer agent. |
|
TP1879 |
HSDVHK-NH2
|
P11 |
|
|
Potent antagonist of the integrin αvβ3-vitronectin interaction (IC50 = 25.72 nM). Blocks proliferation and induces apoptosis in HUVECs; antiangiogenic. |
|
T75835 |
HSDVHK-NH2 TFA
|
|
|
|
HSDVHK-NH2 TFA acts as an antagonist to the αvβ3-vitronectin integrin interaction, displaying an inhibitory concentration (IC 50) of 1.74 pg/mL (2.414 pM) [1] [2]. |
|
T68462 |
D-Ornithine lactam
|
|
|
|
D-Ornithine lactam is a building block. It has been used in the synthesis of hepatitis C virus non-structural protein 5B inhibitors, as well as αVβ3 integrin receptor antagonists. |
|
T75990 |
Cyclo(Arg-Gly-Asp-D-Phe-Val)
|
|
|
|
Cyclo(Arg-Gly-Asp-D-Phe-Val) is an integrin αvβ3 inhibitor with antitumor properties, utilized in the research of acute myeloid leukemia [1]. |
|
T76807 |
Etaracizumab
|
|
|
|
Etaracizumab (LM 609), an αvβ3 integrin IgG1 monoclonal antibody, effectively inhibits angiogenesis and melanoma tumor growth, offering a potential avenue for anticancer research [1]. |
|
T74400 |
TC113
|
|
|
|
TC113, a Gemcitabine (GEM)-based conjugate incorporating the c(RGDyK) sequence, is internalized by A549 cells via the integrin αvβ3 pathway. It demonstrates significant antiproliferative effects on both WM266.4 and A549 ... |
|
T10920 |
Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA
|
|
Others
|
|
Arg-Gly-Asp-D-Phe-Val (TFA) has anti-tumor activity and is an inhibitor of integrin αvβ3. |
|
T82516 |
E(c(RGDfK))₂
|
|
|
|
E(c(RGDfK)) is an αvβ3 integrin-specific binding moiety with tumor-targeting properties, demonstrating increased uptake in human ovarian cancer OVCAR-3 xenograft tumors, suggesting potential utility in cancer research [1... |
|
T78064 |
Synstatin (92-119)
|
SSTN92-119 |
Integrin
|
|
Synstatin (92-119) serves as an anti-tumor agent by suppressing angiogenesis and cancer cell invasion, chiefly through the down-regulation of integrin αvβ3 and attenuation of angiogenic growth factor activation, specific... |
|
T75761 |
Gly-Arg-Gly-Asp-Ser TFA
|
GRGDS TFA |
|
|
Gly-Arg-Gly-Asp-Ser (TFA), a pentapeptide comprising the cell-binding domain of osteopontin (a glycoprotein), interacts with integrin receptors αvβ3 and αvβ5, exhibiting respective estimated IC50 values of approximately ... |
|
TP2098 |
Echistatin
|
Echistatin, α1 isoform |
|
|
Potent irreversible αVβ3 integrin antagonist (Ki = 0.27 nM). Disrupts attachment of osteoclasts to bone and inhibits bone reabsorption (IC50 = 0.1 nM). Prevents ADP-induced platelet aggregation via inhibition of glycopro... |
|
TP1974 |
Obtustatin
|
|
|
|
Highly potent integrin α1β1 inhibitor (IC50 = 0.8 nM for α1β1 binding to type IV collagen). Selective for α1β1 over α2β1, αIIbβ3, αvβ3, α4β1, α5β6, α9β1 and α4β7. Inhibits FGF2-stimulated angiogenesis in the chicken chor... |
|
T76068 |
Cyclo(Arg-Gly-Asp-D-Phe-Cys) TFA
|
|
|
|
Cyclo(Arg-Gly-Asp-D-Phe-Cys) TFA (Cyclo RGDfC) TFA, a cyclic RGD peptide, displays a high affinity for αvβ3 integrin, effectively disrupting cell-integrin interactions. It suppresses pluripotent marker expression in embr... |
|
T83736 |
RTDLDSLRTYTL TFA
|
|
|
|
RTDLDSLRTYTL is a ligand for αVβ6 integrin, exhibiting selective inhibition of fibronectin's binding to αVβ6 integrin with considerably less effect on the interactions between vitronectin and αVβ3 or αVβ5, as well as fib... |
|
TP1343 |
RGD Trifluoroacetate
|
|
|
|
RGD Trifluoroacetate is a tripeptide that effectively triggers cell adhesion, addresses certain cell lines and elicits specific cell responses; RGD Trifluoroacetate binds to integrins.RGD Trifluoroacetate is the most eff... |
|
T70368 |
SF0166
|
|
|
|
SF0166 is a potent, selective antagonist of α v β 3, demonstrating IC 50 values of 0.6 nM for α v β 3, 8 nM for α v β 6, and 13 nM for α v β 8. It effectively inhibits cellular adhesion to vitronectin in human, rat, rabb... |
